Advertisement
PRMA Consulting - Integrated Evidence Generation 2.0

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Research development

Research & Development is essential in all industries. And, when it comes to the Biopharmaceutical research industry, R&D services not only generates income for the companies involved in the research but it often brings results in lives being saved, or at least enhancement in patient's lives. The development for many companies requires the perfect Pharmaceutical research & development. There has been a great deal of research and development in this industry by the doctors and scientists all over the world. Reliable Pharmaceutical R&D services allow companies to follow manufacturing procedures, quality control measures being taken, production scope and technical know-how.

Pharmacogenomic Evaluation in Lung Diseases

A growing need

More than one billion people are impacted by chronic and acute lung diseases globally Infact noncommunicable diseases such as chronic respiratory diseases are among the biggest reasons for fatality WHO

Nanocrystal Technology Applied to the Treatment and Diagnosis of Neurodegenerative Diseases

An obstacle in the development of new therapies is often the poor solubility of many drugs in the research pipelineAn obstacle in the development of new therapies is often the poor solubility of many drugs in the research pipeline Almost per cent of them have a little or no water solubility The term poor solubility applies when the maximum concent...

ANTI-FUNGAL RESISTANCE

Magnitude of the problem and impact

Fungi are ubiquitous in nature and cause disease in humans animals and especially plants

Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2

The SARSCoV pandemic has required new methods for rapidly developing effective vaccines and drugs to treat COVID patients

Role of miRNAs in Neurodegeneration

In disease causing mechanisms and tools of biomarker discovery and therapeutics

Neurodegenerative diseases such as Alzheimers disease AD Parkinsons disease PD Huntingtons disease HD and Amyotrophic lateral sclerosis ALS are a group of agerelated progressive disorders initiated by the neuronal loss that eventually leads to cognitive and movement disorders

Building a Biomedical Diagnostic Research Hub in Asia

Menarini AsiaPacific is just over a decade old having established its regional headquarters in Singapore back in November

Innovation for the Elimination of Neglected Tropical Diseases

Neglected tropical diseases NTDs affect more than one billion people worldwide Although this group of infectious conditions corresponds to per cent of the global disease burden no innovative drugs have been developed in this field

How to Use Pharmacogenomic Information to Reduce the Risk of Experiencing Adverse Events

Pharmacogenomics is the study of the genes their structure function polymorphisms transcription and translation how they interact with each other and with environment

COVID Vaccines

Walking around problems and solutions

Although the vaccines currently approved to prevent the infection caused by the severe acute respiratory syndrome coronavirus SARSCoV known as coronavirus disease COVID and emerging variants have shown to greatly reduce the rates of serious illness and death they appear not fully effective at preventing the infection and disease and long COVID ca...

Drug Development in the Technology Era

Legal Considerations for Computer-Assisted Drug Design

With the cost of developing a new pharmaceutical product currently hovering around US m to USm and taking approximately ten years from product inception to approval the pharmaceutical industry is understandably keen to identify ways to reduce these metrics

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEA SGS - ADVANCED ANALYTICS Adare Pharma Solutions - Pediatric Formulation Solutions Thermo Fisher Scientific - 60th year celebration of The Gibco brand Thermo Fisher Scientific - LC-MS biopharmaceutical applications CPC - The Future of Aseptic Connections in Cell and Gene Therapies CPHI PMEC China - Virtual Expo Connect ThermoFisher - Accekerate therapeutic development